Acadia Pharmaceuticals | ACAD - Funcionários Número total

Preço das Ações
21.74
Mudança Diária
-0.83 -3.68%
Mensal
-1.05%
Anual
49.11%
Q2 Previsão
21.15




Funcionários Alterar Data
Acadia Pharmaceuticals 653 56 2024-12
ALKERMES 1.8K 300 2024-12
Alnylam Pharmaceuticals 2.23K 130 2024-12
Biogen 7.6K 35 2024-12
BioMarin Pharmaceutical 3.04K 361 2024-12
Bristol-Myers Squibb 34.1K 0 2024-12
Cara Therapeutics 55 51 2023-12
Corcept Therapeutics 500 148 2024-12
Cytokinetics 498 75 2024-12
Eisai 13.51K 2.44K 2025-12
Eli Lilly 47K 4K 2024-12
Incyte 2.62K 93 2024-12
J&J 138.1K 6.2K 2024-12
Moderna 5.8K 200 2024-12
Neurocrine Biosciences 1.8K 400 2024-12
Pfizer 81K 7K 2024-12
Prothena 163 10 2024-12
PTC Therapeutics 939 49 2024-12
Sarepta Therapeutics 1.37K 58 2024-12
Ultragenyx Pharmaceutical 1.29K 18 2024-12
Vanda Pharmaceuticals 203 87 2023-12
Vertex Pharmaceuticals 6.1K 700 2024-12